Because attenuated withdrawal syndrome is seen after intracerebroventricular application of NPY [54], [55] and because NPY is an orexigenic peptide, it can be hypothesized that NPY is involved in an endogenous counter-regulatory mechanism to opioid withdrawal. This evidence concerns the gene NPY and substance withdrawal syndrome.